Premium
A New Delhi based pharmaceutical company backed by private equity firm Quadria Capital will acquire a distressed bulk drugs maker,...
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.